Finally, the TgAPP21 rat model of AD, which expresses pathogenic APP, displayed increased microglia activation within the corpus callosum, cingulum, internal capsule, and hippocampus following 2 months of angiotensin II administration at approximately 10 months of age [312]. This evidence concerns the gene AGT and Alzheimer disease.